Long QT Syndrome: Genotype-Phenotype Correlations

Cardiac Electrophysiology: Fourth Edition

Volumn , Issue , 2004, Pages 651-659

  Schwartz, Peter J ^a,b   Priori, Silvia G ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904144646     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-7216-0323-8/50073-7     Document Type: Chapter

References (42)

1. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80:805-811.
2. Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
3. Zipes DP The long QT interval syndrome. A Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1991, 84:1414-1419.
4. Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002, 110:381-388.
5. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KvLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12:17-23.
6. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421:634-639.
7. Ks cardiac potassium current. Nature 1996, 384:78-80.
8. Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97:175-187.
9. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS Diagnostic criteria for the long QT syndrome: An update. Circulation 1993, 88:782-784.
10. Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. Circulation 2000, 102:1178-1185.
11. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003, 348:1866-1874.
12. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995, 92:2929-2934.
13. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995, 92:3381-3386.
14. + channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Circ Res 1996, 78:1009-1015.
15. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long QT syndrome. Gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103:89-95.
16. Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long QT syndrome. ECG findings identify genotypes. Circulation 2000, 102:2849-2855.
17. Dausse E, Berthet M, Denjoy I, et al. A mutation in HERG associated with notched T waves in long-QT syndrome. J Mol Cell Cardiol 1996, 28:1609-1615.
18. Malfatto G, Beria G, Sala S, et al. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol 1994, 23:296-301.
19. Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003, 107:838-844.
20. Shimizu W, Antzelevitch C Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998, 98:2314-2322.
21. Shimizu W, Antzelevitch C Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997, 96:2038-2047.
22. + current. J Gen Physiol 1990, 96:195-215.
23. Swan H, Viitasalo M, Piippo K, et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999, 34:823-829.
24. Stramba-Badiale M, Priori SG, Napolitano C, et al. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: A key to sudden death during sleep?. Ital Heart J 2000, 1:323-328.
25. Schechter E, Freeman CC, Lazzara R Afterdepolarizations as a mechanism for the long QT syndrome: Electrophysiologic studies of a case. J Am Coll Cardiol 1984, 3:1556-1561.
26. Shimizu W, Noda T, Takaki H, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003, 41:633-642.
27. Tanabe Y, Inagaki M, Kurita T, et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2001, 37:911-919.
28. Shimizu W, Tanabe Y, Aiba T, et al. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2002, 39:1984-1991.
29. Schwartz PJ, Zaza A, Locati E, Moss AJ Stress and sudden death. The case of the long QT syndrome. Circulation 1991, 83(suppl II):II71-II80.
30. Wilde AAM, Jongbloed RJE, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KvLQT1-related patients (LQTS1). J Am Coll Cardiol 1999, 33:327-332.
31. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295:496-499.
32. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the Long QT Syndrome. N Engl J Med 1998, 339:960-965. for the International Long-QT Syndrome Registry Research Group.
33. Donger C, Denjoy I, Berthet M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997, 96:2778-2781.
34. January CT, Gong Q, Zhou Z Long QT syndrome: Cellular basis and arrhythmia mechanism in LQT2. J Cardiovasc Electrophysiol 2000, 11:1413-1418.
35. Huang FD, Chen J, Lin M, et al. Long-QT syndrome-associated missense mutations in the pore helix of the HERG potassium channel. Circulation 2001, 104:1071-1075.
36. Moss AJ, Zareba W, Kaufman ES, et al. Increased risk of arrhythmic events in long QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002, 105:794-799.
37. Schwartz PJ Another role for the sympathetic nervous system in the long QT syndrome?. J Cardiovasc Electrophysiol 2001, 12:500-502.
38. Schwartz PJ, Periti M, Malliani A The long QT syndrome. Am Heart J 1975, 89:378-390.
39. Schwartz PJ Idiopathic long QT syndrome: Progress and questions. Am Heart J 1985, 109:399-411.
40. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of β-blocker therapy in congenital long QT syndrome. Circulation 2000, 101:616-623.
41. Vincent GM, Bithell C, Schwartz PJ, et al. Efficacy of beta-blockers in the LQT1 genotype of long QT syndrome (abstract). Circulation 2003 (in press).
42. Cerrone M, Spazzolini C, Priori SG, et al. Left cardiac sympathetic denervation in the management of the long QT syndrome. A worldwide survey. Circulation 2002, 106:II-701.